Europe — EMA
Nanospect (Human Serum Albumin)
GNH USA supplies Nanospect (Human Serum Albumin), a volume expander for hypovolemia, hypoalbuminemia, shock and burns. Request a quote for global supply.
Request sourcing
What is Human Serum Albumin?
Human Serum Albumin, the active ingredient in Nanospect, is a volume expander presented as a sterile injectable solution for intravenous and subcutaneous use. It is employed to restore circulatory volume in patients with hypovolemia, hypoalbuminemia, shock or severe burns in acute care environments.
GNH USA supplies Nanospect as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to EU manufacturing standards and provides regulatory documentation for importers. Products are shipped under controlled temperature conditions to maintain stability and are supported by a dedicated technical service team.
What is Human Serum Albumin used for?
Nanospect is used as a volume expander to address conditions where plasma oncotic pressure is reduced. - Hypovolemia: restores intravascular volume and improves tissue perfusion. - Hypoalbuminemia: raises serum albumin levels and supports oncotic balance. - Shock: contributes to hemodynamic stabilization during circulatory collapse. - Burns: provides plasma volume replacement in extensive fluid loss.
What are the side effects of Human Serum Albumin?
Human Serum Albumin may be associated with a range of adverse reactions.
Common Side Effects: - Fever or chills during infusion. - Mild hypotension or transient blood pressure changes. - Headache or dizziness. - Nausea or mild gastrointestinal discomfort. - Local irritation at the injection site. - Transient increase in serum calcium.
Serious or Rare Side Effects: - Anaphylactic or severe allergic reactions. - Acute hemolysis. - Pulmonary edema due to volume overload. - Thromboembolic events. - Severe hypertension. - Renal dysfunction or failure.
What precautions apply to Human Serum Albumin?
When using Nanospect, clinicians should consider several safety measures. - Patient assessment: evaluate volume status and cardiac function before administration. - Infusion rate: administer slowly to reduce risk of hypotension. - Monitoring: observe vital signs and serum electrolytes during and after infusion. - Contraindications: avoid in patients with known hypersensitivity to albumin products. - Storage: Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.
What does Human Serum Albumin interact with?
Human Serum Albumin can influence the pharmacokinetics of other agents.
Major Interactions (Avoid): - Diuretics: may exacerbate volume depletion if albumin is given concurrently. - Vasopressors: high volume expansion can blunt intended pressor effects.
Moderate Interactions (Monitor Closely): - Anticoagulants: altered plasma protein binding may affect anticoagulant levels. - Antibiotics (e.g., penicillins): protein binding changes can modify free drug concentrations. - Hormonal therapies: albumin may affect distribution of steroid hormones.



